Boston Scientific Corp (BSX)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 9,896,000 | 8,727,000 | 8,177,000 | 6,448,000 | 7,620,000 |
| Revenue | US$ in thousands | 13,975,000 | 12,190,000 | 11,625,000 | 9,552,000 | 10,348,000 |
| Gross profit margin | 70.81% | 71.59% | 70.34% | 67.50% | 73.64% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $9,896,000K ÷ $13,975,000K
= 70.81%
The gross profit margin of Boston Scientific Corp. has demonstrated fluctuations over the past five years, ranging from 65.05% in 2020 to a peak of 70.97% in 2019. It is observed that the margin improved steadily from 2019 to 2022, reaching its highest point at 68.81% before a slight increase to 69.49% in 2023.
The company's ability to maintain a gross profit margin above 65% indicates efficient cost management and strong pricing strategies. However, the fluctuations in the margin suggest potential challenges in managing production costs and pricing in response to market dynamics and competition. It would be important for Boston Scientific Corp. to continue monitoring and optimizing its cost structure to sustain and potentially enhance its gross profit margin in the future.
Peer comparison
Dec 31, 2023